A Review of Methods for Computational Prediction of Blood-Brain Partitioning

Advances in combinatorial synthesis and high throughput screening have resulted in libraries containing hun- dreds of thousands of drug candidate compounds. Computational prediction of properties that will determine the utility of a drug molecule has become a sine qua non in the pharmaceutical industry, because of the appreciation that ADMET properties must be considered early in the discovery process and the higher cost of experimental alternatives. In this paper we are reviewing the models developed recently to predict the permeation of organic molecules through the blood-brain barrier. The blood-brain barrier is in essence a mechanism for preventing the entry of unnecessary or toxic blood molecules into the central nervous system, while allowing the circula- tion of adequate amounts of arterial blood through brain tis- sue. Since the brain consumes more than 20% of available oxygen in the human body, it is important to maintain suffi- cient amounts of blood while excluding potentially harmful molecules. (1-3). Already in the late 19 th century the presence of the blood- brain barrier became evident, when scientists observed that dyes readily penetrated in other organs from the blood cir- culation, but not in the brain.

[1]  Akira Tsuji,et al.  Drug delivery through the blood-brain barrier , 1996 .

[2]  Christian R Noe,et al.  In silico prediction models for blood-brain barrier permeation. , 2004, Current medicinal chemistry.

[3]  Gabriele Cruciani,et al.  Suitability of molecular descriptors for database mining. A comparative analysis. , 2002, Journal of medicinal chemistry.

[4]  David J. Begley,et al.  Potential of Immobilized Artificial Membranes for Predicting Drug Penetration Across the Blood−Brain Barrier , 1998, Pharmaceutical Research.

[5]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[6]  D D Breimer,et al.  The blood-brain barrier in neuroinflammatory diseases. , 1997, Pharmacological reviews.

[7]  M Danhof,et al.  Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. , 1988, The Journal of pharmacology and experimental therapeutics.

[8]  D. E. Clark,et al.  Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. , 1999, Journal of pharmaceutical sciences.

[9]  D. E. Clark In silico prediction of blood-brain barrier permeation. , 2003, Drug discovery today.

[10]  A. Seelig,et al.  A method to determine the ability of drugs to diffuse through the blood-brain barrier. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Juan M. Luco,et al.  Prediction of the Brain-Blood Distribution of a Large Set of Drugs from Structurally Derived Descriptors Using Partial Least-Squares (PLS) Modeling , 1999, J. Chem. Inf. Comput. Sci..

[12]  R Griffiths,et al.  Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. , 1988, Journal of medicinal chemistry.

[13]  Yiannis N. Kaznessis,et al.  Prediction of blood-brain partitioning using Monte Carlo simulations of molecules in water , 2001, J. Comput. Aided Mol. Des..

[14]  William L. Jorgensen,et al.  Monte Carlo simulations of the hydration of substituted benzenes with OPLS potential functions , 1993, J. Comput. Chem..

[15]  M Gumbleton,et al.  Progress and limitations in the use of in vitro cell cultures to serve as a permeability screen for the blood-brain barrier. , 2001, Journal of pharmaceutical sciences.

[16]  Per Sjöberg MOLSURF ‐ a Generator of Chemical Descriptors for QSAR , 2007 .

[17]  N. Sheppard Hydrogen Bonding , 1971, Nature.

[18]  Emi Nakashima,et al.  New approaches to in vitro models of blood-brain barrier drug transport. , 2003, Drug discovery today.

[19]  Wolfgang Sippl,et al.  Computational Approaches for the Prediction of Blood-Brain Barrier Permeation , 2002 .

[20]  Xavier Llorà,et al.  Development of a Genetic Algorithm to Design and Identify Peptides that can Cross the Blood-Brain Barrier , 2003 .

[21]  Tingjun Hou,et al.  ADME Evaluation in Drug Discovery. 3. Modeling Blood-Brain Barrier Partitioning Using Simple Molecular Descriptors , 2003, J. Chem. Inf. Comput. Sci..

[22]  Tingjun Hou,et al.  ADME evaluation in drug discovery , 2002, Journal of molecular modeling.

[23]  U Norinder,et al.  Theoretical calculation and prediction of brain-blood partitioning of organic solutes using MolSurf parametrization and PLS statistics. , 1998, Journal of pharmaceutical sciences.

[24]  William L. Jorgensen,et al.  A Quantum Mechanical and Molecular Mechanical Method Based on CM1A Charges: Applications to Solvent Effects on Organic Equilibria and Reactions , 1998 .

[25]  Xiaojie Xu,et al.  1. Applications of genetic algorithms to the prediction of blood-brain partitioning of a large set of drugs , 2002 .

[26]  W. Liang,et al.  Predicting blood-brain barrier penetration of drugs by polar molecular surface area and molecular volume. , 2001, Acta pharmacologica Sinica.

[27]  Hans-Joachim Galla,et al.  An improved low-permeability in vitro-model of the blood–brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol , 1999, Brain Research.

[28]  W L Jorgensen,et al.  Prediction of drug solubility from Monte Carlo simulations. , 2000, Bioorganic & medicinal chemistry letters.

[29]  Philip L. Smith,et al.  In vitro models to predict blood-brain barrier permeability , 1997 .

[30]  J. Brillault,et al.  Prediction of Drug Transport Through the Blood-Brain Barrier in Vivo: A Comparison Between Two in Vitro Cell Models , 2002, Pharmaceutical Research.

[31]  T R Stouch,et al.  Solute diffusion in lipid bilayer membranes: an atomic level study by molecular dynamics simulation. , 1993, Biochemistry.

[32]  N el Tayar,et al.  Partitioning of solutes in different solvent systems: the contribution of hydrogen-bonding capacity and polarity. , 1991, Journal of pharmaceutical sciences.

[33]  Denis M. Bayada,et al.  Polar Molecular Surface as a Dominating Determinant for Oral Absorption and Brain Penetration of Drugs , 1999, Pharmaceutical Research.

[34]  Harpreet S. Chadha,et al.  Hydrogen-bonding. Part 36. Determination of blood brain distribution using octanol-water partition coefficients. , 1995, Drug design and discovery.

[35]  W. L. Jorgensen,et al.  Prediction of Properties from Simulations: Free Energies of Solvation in Hexadecane, Octanol, and Water , 2000 .

[36]  Harpreet S. Chadha,et al.  Hydrogen bonding. 33. Factors that influence the distribution of solutes between blood and brain. , 1994, Journal of pharmaceutical sciences.

[37]  H. van de Waterbeemd,et al.  ADMET in silico modelling: towards prediction paradise? , 2003, Nature reviews. Drug discovery.

[38]  Michał J. Markuszewski,et al.  Brain/blood distribution described by a combination of partition coefficient and molecular mass , 1996 .

[39]  B. Jin,et al.  Characterization of Lipid Membrane Dynamics by Simulation: 3. Probing Molecular Transport Across the Phospholipid Bilayer , 1996, Pharmaceutical Research.

[40]  M. Abraham,et al.  The use of characteristic volumes to measure cavity terms in reversed phase liquid chromatography , 1987 .

[41]  Han van de Waterbeemd High-throughput and in silico techniques in drug metabolism and pharmacokinetics. , 2002, Current opinion in drug discovery & development.

[42]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[43]  W. Pardridge Blood-brain barrier biology and methodology. , 1999, Journal of neurovirology.

[44]  Han van de Waterbeemd,et al.  High-throughput and in silico techniques in drug metabolism and pharmacokinetics. , 2002 .

[45]  David A Winkler,et al.  Modelling blood-brain barrier partitioning using Bayesian neural nets. , 2004, Journal of molecular graphics & modelling.

[46]  M. Kansy,et al.  Hydrogen-Bonding Capacity and Brain Penetration , 1992, Chimia (Basel).

[47]  Meihua Rose Feng,et al.  Assessment of blood-brain barrier penetration: in silico, in vitro and in vivo. , 2002, Current drug metabolism.

[48]  C. Lohmann,et al.  Predicting Blood-Brain Barrier Permeability of Drugs: Evaluation of Different In Vitro Assays , 2002, Journal of drug targeting.

[49]  Michael C. Hutter,et al.  Prediction of blood–brain barrier permeation using quantum chemically derived information , 2003, J. Comput. Aided Mol. Des..

[50]  M. Feher,et al.  A simple model for the prediction of blood-brain partitioning. , 2000, International journal of pharmaceutics.

[51]  Harpreet S. Chadha,et al.  Molecular Factors Influencing Drug Transfer across the Blood‐Brain Barrier , 1997, The Journal of pharmacy and pharmacology.

[52]  M Pastor,et al.  VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[53]  F. Lombardo,et al.  Computation of brain-blood partitioning of organic solutes via free energy calculations. , 1996, Journal of medicinal chemistry.

[54]  A. J. Hopfinger,et al.  Predicting Blood–Brain Barrier Partitioning of Organic Molecules Using Membrane–Interaction QSAR Analysis , 2002, Pharmaceutical Research.

[55]  Thomas Hofmann,et al.  Predicting CNS Permeability of Drug Molecules: Comparison of Neural Network and Support Vector Machine Algorithms , 2002, J. Comput. Biol..

[56]  A. Seelig,et al.  Blood-Brain Barrier Permeation: Molecular Parameters Governing Passive Diffusion , 1998, The Journal of Membrane Biology.

[57]  S. Wold,et al.  PLS: Partial Least Squares Projections to Latent Structures , 1993 .